Abstract:Nasal natural killer/T-cell lymphoma (N-NK/T-L) is prevalent in China. To further characterize this neoplasm, 36 cases of N-NK/T-L from 304 cases of malignant lymphomas in the north China area were investigated by histopathology, immunophenotyping, and genomic analysis of c-kit, in comparison with 11 cases of B-cell lymphoma (BCL) at the same region and 5 cases of nodal peripheral T-cell lymphoma (PTCL) (unspecified). Histopathologically, N-NK/T-L was characterized by coagulative necrosis, inflammatory background, and angiodestructive growth pattern. In 36 cases of N-NK/T-L, 27 cases (75.0%) were stained for CD45RO and 25 (72.2%) for CD3ε. Thirty cases (83.3%) were positive for T-cell intracellular antigen–1, 22 (61.1%) for granzyme B, 18 (50.0%) for CD56, and 11 (30.6%) for CD30, whereas none was positive for CD117. All 5 cases of PTCL displayed positive staining for CD45RO and T-cell intracellular antigen–1, 3 cases for CD3ε, but only 1 case for granzyme B. All 11 BCLs presented positive staining for CD20 and CD79a but negative for other antibodies. A significant relationship was observed between neoplastic cells pleomorphism and granzyme B expression (P < .05). Despite the fact that all cases were negative for CD117 staining, genomic sequences of c-kit 11 and exon 17 sequencing showed that 8 (26%) of 31 cases N-NK/T-L proved to contain genomic mutations, including 4 cases in exon 11 and 4 in exon 17. For the control group, only 1 (9%) of 11 BCLs and 1 (20%) of 5 cases of PTCL were detected to harbor mutations in exon 11. All mutations detected in 3 groups were missense by base substitution, and codes 571, 572, and 821 were hot spots. The results suggested that, in addition to histological features and routine immunophenotyping, granzyme B expression should be a more reliable marker in correct diagnosis of N-NK/T-L, and genetic analysis of c-kit mutation should be helpful in the diagnosis of this tumor.

[Preparation of Anti-Hnok Antibodies and Expression Examination of NOK in the Lung Cancer Tissues].

Generation and application of the NOK/STYK1 monoclonal antibody

The Clinic Significance of NOK Protein Expression in NSCLC

High Novel Oncogene with Kinase-Domain (NOK) Gene Expression is Associated with the Progression of Renal Cell Carcinoma.

Preparation and Identification of Polyclonal Antibodies Against LPTS

Nkx2-1: a Novel Tumor Biomarker of Lung Cancer

Pan-cancer analysis of nemo-like kinase (NLK) expression convergence to pancreatic adenocarcinoma that has diagnostic, prognostic and treatment value

Preparation and Characterization of Monoclonal Antibodies Against Nucleostemin, a Protein That Controls Cell Proliferation in Stem Cells and Cancer Cells

[Expression and its Clinical Significance of NOK, EGFR in NSCLC.].

A Novel Protein Tyrosine Kinase Nok That Shares Homology With Platelet-Derived Growth Factor/Fibroblast Growth Factor Receptors Induces Tumorigenesis And Metastasis In Nude Mice

NOK/STYK1 Promotes the Genesis and Remodeling of Blood and Lymphatic Vessels During Tumor Progression

Preparation of polyclonal antibodies to the chicken Beclin1 protein and its application in the detection of nephropathogenic infectious bronchitis virus

[Preparation, Identification, and Analysis on Tissue Chips of Polyclonal Anti-Peptide Antibody to Chemokine-Like Factor 1].

PUB045 Anti-Tumor Effect of Honokiol in Lung Squamous Cell Carcinoma

NOK promotes tumorigenesis through coordinating epidermal growth factor receptor to boost the downstream signaling in breast cancer

[Construction and identification of procaryotic expression vector of human NIT1 gene].

Preparation of Anti-Asns Monoclonal Antibody and Detection of ASNS Expression in Tumor

NOK/STYK1 Interacts with GSK-3β and Mediates Ser9 Phosphorylation Through Activated Akt

Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas.

Preparation and Functional Identification of A Monoclonal Antibody Against the Recombinant Soluble Human Nkp30 Receptor

Prokaryotic Expression, Polyclonal Antibody Preparation, and Sub-Cellular Localization Analysis of Na+, K+-ATPase Β2 Subunit